Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof
US-2024252624-A1 · Aug 1, 2024 · US
This page is not indexed by search engines while we improve data quality.
Mebatsion Teshome patents
Mebatsion Teshome holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | Aug 11, 2015 |
| Latest publication | Aug 1, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
US-9567606-B2 · Feb 14, 2017 · US
Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
US-9114108-B2 · Aug 25, 2015 · US
Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
US-9101598-B2 · Aug 11, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof
US-2024252624-A1 · Aug 1, 2024 · US
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
US-9567606-B2 · Feb 14, 2017 · US
Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
US-9114108-B2 · Aug 25, 2015 · US
Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
US-9101598-B2 · Aug 11, 2015 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |